These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3418727)
1. Spinal cord penetration of intrathecally administered cytarabine and methotrexate: a quantitative autoradiographic study. Burch PA; Grossman SA; Reinhard CS J Natl Cancer Inst; 1988 Oct; 80(15):1211-6. PubMed ID: 3418727 [TBL] [Abstract][Full Text] [Related]
2. Effects of intrathecal methotrexate and cytosine arabinoside on the radiation tolerance of the rat spinal cord. van der Kogel AJ; Sissingh HA Radiother Oncol; 1985 Nov; 4(3):239-51. PubMed ID: 3841220 [TBL] [Abstract][Full Text] [Related]
3. The intracerebral penetration of intraventricularly administered methotrexate: a quantitative autoradiographic study. Grossman SA; Reinhard CS; Loats HL J Neurooncol; 1989 Nov; 7(4):319-28. PubMed ID: 2585028 [TBL] [Abstract][Full Text] [Related]
4. Breast cancer leptomeningeal metastasis: the results of combined treatment and the comparison of methotrexate and liposomal cytarabine as intra-cerebrospinal fluid chemotherapy. Niwińska A; Rudnicka H; Murawska M Clin Breast Cancer; 2015 Feb; 15(1):66-72. PubMed ID: 25287959 [TBL] [Abstract][Full Text] [Related]
5. Myelopathy following intrathecal chemotherapy in adults: a single institution experience. Cachia D; Kamiya-Matsuoka C; Pinnix CC; Chi L; Kantarjian HM; Cortes JE; Daver N; Woodman K J Neurooncol; 2015 Apr; 122(2):391-8. PubMed ID: 25666482 [TBL] [Abstract][Full Text] [Related]
6. [Clinical research on acute paraplegia resulting from intrathecal chemotherapy]. Cheng M; Xue L; Li YJ; Jiang Q; Zhang J; Gao XG Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(5):362-364. PubMed ID: 29429247 [No Abstract] [Full Text] [Related]
7. Perspective graphics as a means of portraying the distribution of radiolabelled ligands in the spinal cord--a pilot study using intrathecally administered 3H morphine. Gregory MA; Brock-Utne JG; Gathiram P; Bux S; Brouckaert CJ Anaesth Intensive Care; 1986 Nov; 14(4):426-30. PubMed ID: 3565728 [TBL] [Abstract][Full Text] [Related]
8. Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities. Kwong YL; Yeung DY; Chan JC Ann Hematol; 2009 Mar; 88(3):193-201. PubMed ID: 19050889 [TBL] [Abstract][Full Text] [Related]
9. Methotrexate myelopathy after intrathecal chemotherapy: a case report. Murata KY; Maeba A; Yamanegi M; Nakanishi I; Ito H J Med Case Rep; 2015 Jun; 9():135. PubMed ID: 26055509 [TBL] [Abstract][Full Text] [Related]
10. Direct administration of methotrexate into the central nervous system of primates. Part 2: Distribution of 3H methotrexate after intrathecal lumbar injection. Yen J; Reiss FL; Kimelberg HK; Bourke RS J Neurosurg; 1978 Jun; 48(6):895-902. PubMed ID: 96229 [TBL] [Abstract][Full Text] [Related]
11. Distribution of label after intrathecal administration of 125I-substance P in the rat. Cridland RA; Yashpal K; Romita VV; Gauthier S; Henry JL Peptides; 1987; 8(2):213-21. PubMed ID: 2438667 [TBL] [Abstract][Full Text] [Related]
12. Rapidly ascending necrotizing myelopathy with widespread brain white matter involvement following intrathecal methotrexate and cytosine arabinoside treatment in an adult with T cell acute lymphoblastic leukemia. Lapucci C; Capello E; Romano N; Guolo F; Mavilio N; Roccatagliata L Neurol Sci; 2018 Sep; 39(9):1637-1639. PubMed ID: 29728935 [No Abstract] [Full Text] [Related]
13. Pharmacokinetics of anticancer drugs in cerebrospinal fluid. Morikawa N; Mori T; Kawashima H; Takeyama M; Hori S Ann Pharmacother; 1998 Oct; 32(10):1008-12. PubMed ID: 9793590 [TBL] [Abstract][Full Text] [Related]
14. Paraplegia following intrathecal chemotherapy: neuropathologic findings and elevation of myelin basic protein. Clark AW; Cohen SR; Nissenblatt MJ; Wilson SK Cancer; 1982 Jul; 50(1):42-7. PubMed ID: 6177392 [TBL] [Abstract][Full Text] [Related]
15. Neurotoxicity of midazolam in the rabbit. Erdine S; Yücel A; Ozyalçin S; Ozyuvaci E; Talu GK; Ahiskali B; Apak H; Savci N Pain; 1999 Mar; 80(1-2):419-23. PubMed ID: 10204757 [TBL] [Abstract][Full Text] [Related]
16. Severe and irreversible myelopathy after concurrent systemic and intrathecal nucleoside analogue treatment for refractory diffuse large B-cell lymphoma: A case report and review of the literature. Alsdorf WH; Schmitz M; Schieferdecker A; Dierlamm J; Bokemeyer C; Binder M J Oncol Pharm Pract; 2016 Jun; 22(3):523-7. PubMed ID: 25655468 [TBL] [Abstract][Full Text] [Related]
17. Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis. Glantz MJ; Van Horn A; Fisher R; Chamberlain MC Cancer; 2010 Apr; 116(8):1947-52. PubMed ID: 20151421 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration. de Lemos ML; Monfared S; Denyssevych T; Hamata L; Jennings S; Thiessen B; Smith S; Waterhouse D J Oncol Pharm Pract; 2009 Mar; 15(1):45-52. PubMed ID: 18772215 [TBL] [Abstract][Full Text] [Related]
19. [Spinal subacute combined degeneration after intrathecal chemotherapy. Report of two cases]. Cartier R L; Parra V J; Puga B; Cardemil D Rev Med Chil; 2018 Jun; 146(6):802-807. PubMed ID: 30148913 [TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics of intrathecal chemotherapy and clinical problems]. Fujimoto T Gan To Kagaku Ryoho; 1984 Aug; 11(8):1536-42. PubMed ID: 6433796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]